(Q37305627)

English

Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies

scientific article published on 23 August 2012

Statements

Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies (English)
0 references
D Mahadevan
E G Chiorean
W B Harris
D D Von Hoff
A Stejskal-Barnett
S P Anthony
A E Younger
D M Rensvold
F Cordova
C F Shelton
M D Becker
J R Garlich
D L Durden
R K Ramanathan
23 August 2012
3319-3327

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit